Personal information

Activities

Employment (9)

Dana-Farber Cancer Institute: Boston, MA, US

2022-01-01 to present | Professor (Cell Biology)
Employment
Source: Self-asserted source
Lewis Cantley

Weill Cornell Medical College: NY, NY, US

2012 to 2022 | Director (Sandra and Edward Meyer Cancer Center)
Employment
Source: Self-asserted source
Lewis Cantley

Beth Israel Deaconess Medical Center: Boston, MA, US

2007 to 2012 | Director (Cancer Center)
Employment
Source: Self-asserted source
Lewis Cantley

Harvard Medical School: Boston, MA, US

2003 to 2012 | Professor (Systems Biology)
Employment
Source: Self-asserted source
Lewis Cantley

Beth Israel Deaconess Medical Center: Boston, MA, US

1992 to 2012 | Division Chief (Division of Signal Transduction /Dept. of Medicine)
Employment
Source: Self-asserted source
Lewis Cantley

Harvard Medical School: Boston, MA, US

1992 to 2003 | Professor (Cell Biology)
Employment
Source: Self-asserted source
Lewis Cantley

Tufts University School of Medicine: Boston, MA, US

1985 to 1992 | Professor (Physiology)
Employment
Source: Self-asserted source
Lewis Cantley

Harvard University: Cambridge, MA, US

1981 to 1985 | Associate Professor (Biochemistry and Molecular Biology)
Employment
Source: Self-asserted source
Lewis Cantley

Harvard University: Cambridge, MA, US

1978 to 1981 | Assistant Professor (Biochemistry and Molecular Biology)
Employment
Source: Self-asserted source
Lewis Cantley

Education and qualifications (3)

Harvard University: Cambridge, MA, US

1978-09 | Postdoc (Membrane Biochemistry)
Education
Source: Self-asserted source
Lewis Cantley

Cornell University: Ithaca, NY, US

1975 | Ph.D. (Biophysical Chemistry)
Education
Source: Self-asserted source
Lewis Cantley

West Virginia Wesleyan College: Buckhannon, WV, US

1971 | B.S. (Chemistry)
Education
Source: Self-asserted source
Lewis Cantley

Funding (4)

Targeting BRCA1-mutant breast cancer cells with folate and vitamin C. Please add your own title.

2024-10-01 to 2025-09-30 | Grant
The Breast Cancer Research Foundation Inc. (New York, US)
GRANT_NUMBER:

BCRF-24-022

Source: check_circle
BCRF ProposalCentral

Targeting BRCA1-mutant breast cancer cells with folate and vitamin C

2023-10-01 to 2024-09-30 | Grant
The Breast Cancer Research Foundation Inc. (New York, US)
GRANT_NUMBER:

BCRF-23-022

Source: check_circle
BCRF ProposalCentral

Targeting BRCA1-mutant breast cancer cells with folate and vitamin C

2022-10-01 to 2023-09-30 | Grant
The Breast Cancer Research Foundation Inc. (New York, US)
GRANT_NUMBER:

BCRF-22-022

Source: check_circle
BCRF ProposalCentral

Targeting BRCA1-mutant breast cancer cells with folate and vitamin C

2021-10-01 to 2022-09-30 | Grant
The Breast Cancer Research Foundation Inc. (New York, US)
GRANT_NUMBER:

BCRF-21-022

Source: check_circle
BCRF ProposalCentral